The Global Single-use Bioprocessing Market is Projected to Reach $26.9 Billion by 2025 - Led by, Sartorius, GE Healthcare, Eppendorf and Lonza - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 7, 2018--The “Single-use Bioprocessing Market Size, Share, & Trends Analysis Report By Product (Simple & Peripheral Elements, Apparatus & Plants, Work Equipment), By Workflow, By End Use, And Segment Forecasts, 2018 - 2025” report has been added to ResearchAndMarkets.com’s offering.The global single-use bioprocessing market size is expected to reach USD 26.89 billion by 2025, exhibiting a CAGR of 13.6% during the forecast period.Low cost associated with operations and construction is recognized as the key factor stimulating the sales of and demand for disposable products. In addition, integration of single-use technology (SUTs) in continuous bioprocess engineering is anticipated to fuel the usage of disposables.
Rising pressure to meet the growing demand for biopharmaceuticals is expected to significantly impact the adoption of SUTs within the bioprocessing industry. Hence, this space is also expected to be benefitted by the rapid growth of biologics. Moreover, SUT helps in enhancing operational capacity, which in turn, prompts biopharmaceutical companies to adopt disposable equipment.
Key FindingsBy product, simple and peripheral elements dominated the market as a result of wide usage in upstream biopharmaceutical production.The apparatus and plants segment is expected to grow at a lucrative pace primarily due to enormous investments in the development of single-use bioreactors (SUBs) and filtration systems.By workflow, the upstream segment is fueled by successful implementation of single-use systems (SUSs) in upstream processing as well as continuous introduction of new products to simplify these processes.On the basis of end use, biopharmaceutical manufacturers dominated the market, with CMOs & CROs accounting for a majority of the share. This is majorly due to continuous expansion of single-use manufacturing facilities by CMOs.Key players include Sartorius AG, GE Healthcare, Eppendorf AG, and Lonza. Firms are engaged in replacing traditional bioprocessing product lines with new SUTs products.Market Dynamics Drivers Several Advantages Associated With the Implementation of SUS in Overall Biomanufacturing ProcessWidespread Adoption of Single-Use Technology Amongst CMOsInvestments Continue to Take Place for Expansion of cGMP ManufacturingCommercial Success of Biopharmaceuticals and Consequent Increased Demand for the Biopharmaceuticals Restraints High Cost of Single-Use EquipmentConcern of Leachables and ExtractablesLimited Adoption in Downstream Processing
Chapter 1 Executive Summary
Chapter 2 Research Methodology
Chapter 3 Single-use Bioprocessing Market Variables, Trends & Scope
Chapter 4 Single-use Bioprocessing Market: Product Estimates & Trend Analysis
Chapter 5 Single-use Bioprocessing Market: Workflow Estimates & Trend Analysis
Chapter 6 Single-use Bioprocessing Market: End-use Estimates & Trend Analysis
Chapter 7 Single-use Bioprocessing Market: Regional Estimates & Trend Analysis
Chapter 8 Competitive LandscapeGeneral Electric Company (GE healthcare)Eppendorf AGCorning IncorporatedThermo Fisher Scientific Inc.Sartorius AGJM BioconnectMerck KGaABoehringer Ingelheim GmbHInfors AGPBS Biotech, IncEntegris, Inc.LONZADanaher CorporationKuhner AGMeissner Filtration Products, Inc.Rentschler Biopharma SE
For more information about this report visit https://www.researchandmarkets.com/research/xgpvp6/the_global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181107005500/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 11/07/2018 08:10 AM/DISC: 11/07/2018 09:34 AM